10 Best-Selling Brand-Name Drugs in 2015

AUGUST 17, 2015
Allison Gilchrist, Associate Editor

9. Januvia (Merck) – $3.8 billion

In 2014, drug researchers analyzed insurance claims from more than 7000 patients with hospitalizations related to heart failure (HF) and determined that this diabetes drug increased the risk of HF hospitalizations by 84%. Last month, however, the largest study analyzing this relationship to date discredited this finding.
US providers have written 9.2 million prescriptions for Januvia this year, making it the eighth-most prescribed drug overall.